KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Short-term Investments (2016 - 2026)

Pacific Biosciences Of California has reported Short-term Investments over the past 16 years, most recently at $215.8 million for Q4 2025.

  • For Q4 2025, Short-term Investments fell 35.5% year-over-year to $215.8 million; the TTM value through Dec 2025 reached $215.8 million, down 35.5%, while the annual FY2025 figure was $215.8 million, 35.5% down from the prior year.
  • Short-term Investments for Q4 2025 was $215.8 million at Pacific Biosciences Of California, down from $242.2 million in the prior quarter.
  • Over five years, Short-term Investments peaked at $684.6 million in Q2 2021 and troughed at $300000.0 in Q3 2023.
  • A 5-year average of $352.3 million and a median of $393.2 million in 2024 define the central range for Short-term Investments.
  • On a YoY basis, Short-term Investments climbed as much as 130955.0% in 2024 and fell as far as 99.94% in 2024.
  • Year by year, Short-term Investments stood at $583.7 million in 2021, then dropped by 23.38% to $447.2 million in 2022, then grew by 0.96% to $451.5 million in 2023, then fell by 25.9% to $334.6 million in 2024, then tumbled by 35.5% to $215.8 million in 2025.
  • Business Quant data shows Short-term Investments for PACB at $215.8 million in Q4 2025, $242.2 million in Q3 2025, and $259.9 million in Q2 2025.